Find trials
Search tips

Vessel Wall Inflammation in Neurosarcoidosis

Overview

About this study

The purpose of this research study is to evaluate for presence and severity of vessel wall inflammation in patients with Neurosarcoidosis.  

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Diagnosed Neurosarcoidosis (NS) in the last 2 years.
  • ≥ 18 and ≤ 85 years of age.
  • Able to consent.
  • Reliable follow up.
  • Recent GFR/creatinine test result on file (30 days or newer).

Exclusion Criteria: 

  • CNS vasculitis other than NS.
  • Any co-existing intracranial pathology which may confound evaluation of NS, such as infection or metastatic disease.
  • Unable to undergo MRI.
  • Severe kidney dysfunction (defined as estimated glomerular filtration rate (GFR) is < 30 mL/min/1.73 m^2).
  • Pregnant, trying to become pregnant, or breast feeding.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 12/8/22. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Girish Bathla, M.B.B.S., M.MED.

Open for enrollment

Contact information:

Suson Walsh CCRP

(507) 293-0039

Walsh.Suson@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20561612

Mayo Clinic Footer